Remote Medical Science Liaison: Rare Neurology

OverviewPronto/a a candidarsi? Prima di farlo, si assicuri di leggere tutti i dettagli relativi a questo lavoro nella descrizione sottostante.In this field-based role, you support medical and scientific objectives for our Rare Disease portfolio by engaging with HCPs and KOLs across AL, GA, MS, and LA. You will translate complex science into actionable...

Chiesi Italia è la filiale italiana del Gruppo Chiesi con sede a Parma, cresciuta nel nucleo dell’Headquarter e sviluppatasi per rispondere al mercato di riferimento che la vede impegnata nelle attività di informazione medico scientifica e commercializzazione dei prodotti Chiesi sul territorio italiano.Per realizzare la sua missione di migliorare la...

Chiesi Italia è alla ricerca di un/una Medical Science Liaison (MSL) per rafforzare la rete scientifica a supporto delle terapie per Angioedema Ereditario nell’ambito Rare Diseases. Territorio nazionale, report diretto all Head of Medical Therapeutic Area Rare Diseases. La funzione prevede sviluppo di relazioni scientifiche con Opinion Leaders, centri di...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Country Compliance Lead | Clinical-stage oncology | Italy (Remote)È il candidato/la candidata ideale per questa opportunità? Lo scopra leggendo la panoramica del ruolo qui sotto.MLA Interim is working with a clinical-stage oncology company on a newly created compliance role in Italy. The business develops targeted therapies, and is preparing for its first...

Overview You will lead the governance of lifecycle management for Chiesi’s Air/Care and Rare products, partnering with R&D, regulatory, manufacturing and quality teams to drive proactive lifecycle practices. This role anchors governance documentation and ensures regulatory compliance across global markets, while enabling cross-functional collaboration and...

Company OverviewÈ il candidato/la candidata ideale per questa opportunità? Lo scopra leggendo la panoramica del ruolo qui sotto.Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases. We...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...